Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
JVSPAC Acquisition | JVSA | Dec 27, 2024 | 10.42 | 0.00 |
JX Luxventure | JXJT | Dec 27, 2024 | 0.81 | 0.00 |
Kadant | KAI | Dec 27, 2024 | 350.80 | -1.72 |
Kairos Pharma | KAPA | Dec 27, 2024 | 1.68 | +0.60 |
Kairous Acquisition | KACL | Dec 27, 2024 | 12.33 | 0.00 |
Kaiser Aluminium | KALU | Dec 27, 2024 | 69.32 | -2.10 |
Kaival Brands Innovations Group | KAVL | Dec 27, 2024 | 0.85 | +4.69 |
Kaixin Holdings | KXIN | Dec 27, 2024 | 1.51 | -3.82 |
Kala Bio | KALA | Dec 27, 2024 | 6.98 | +0.65 |
Kaltura | KLTR | Dec 27, 2024 | 2.23 | -3.04 |
KalVista Pharmaceuticals | KALV | Dec 27, 2024 | 8.53 | -3.40 |
Kamada | KMDA | Dec 27, 2024 | 5.92 | -1.91 |
Kandi Technologies Group | KNDI | Dec 27, 2024 | 0.98 | +4.57 |
Kanzhun ADR | BZ | Dec 27, 2024 | 13.87 | +0.80 |
Karat Packaging | KRT | Dec 27, 2024 | 30.03 | -2.21 |
Karooooo | KARO | Dec 27, 2024 | 45.85 | -3.39 |
Kartoon Studios | TOON | Dec 27, 2024 | 0.66 | +7.70 |
Karyopharm Therapeutics | KPTI | Dec 27, 2024 | 0.70 | +16.83 |
Katapult | KPLT | Dec 27, 2024 | 5.81 | +3.01 |
Kayne Anderson BDC | KBDC | Dec 27, 2024 | 16.75 | -0.48 |
Kayne Anderson Energy Infrastructure Fund | KYN | Dec 27, 2024 | 12.20 | -0.73 |
Kazia Therapeutics ADR | KZIA | Dec 27, 2024 | 3.07 | +1.66 |
KB Financial Group ADR | KB | Dec 27, 2024 | 57.70 | -1.06 |
KB Home | KBH | Dec 27, 2024 | 65.69 | -0.88 |
KBR | KBR | Dec 27, 2024 | 57.05 | -1.02 |
KBW Bank Powershares | KBWB | Dec 27, 2024 | 65.79 | -0.83 |
KBW High Div Yield Financial Powershares | KBWD | Dec 27, 2024 | 14.62 | -0.48 |
KBW Prem Yield Equity REIT Powershares | KBWY | Dec 27, 2024 | 17.78 | -1.71 |
KBW Prop & Casuality Insur Powershares | KBWP | Dec 27, 2024 | 116.03 | -0.80 |
KBW Regional Banking Powershares | KBWR | Dec 27, 2024 | 59.93 | -1.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.